Sector Update: Health Care Stocks Climb Tuesday Afternoon

MT Newswires Live
16 hours ago

Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index adding 2.2% and the Health Care Select Sector SPDR Fund (XLV) advancing 2%.

The iShares Biotechnology ETF (IBB) climbed 2.5%.

In corporate news, Novo Nordisk (NVO) has reduced the price of its weight management drug Wegovy by up to 33% in India, Reuters reported. Novo shares were up 6.8%.

Surmodics (SRDX) shares surged 49% after the company said the US District Court for the Northern District of Illinois denied a request by the Federal Trade Commission and certain state regulators for a preliminary injunction that would have blocked its planned acquisition by a GTCR affiliate.

Cytokinetics (CYTK) is expected to launch aficamten in 2026 with a potentially differentiated risk evaluation and mitigation strategy that could boost demand, RBC Capital Markets said in a Monday note. RBC reiterated an outperform rating for Cytokinetics and raised its price target to $87 from $82. Cytokinetics shares rose 4.1%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10